Allergan Aesthetics Presents New Data on Facial Injectable Portfolio at IMCAS 2026
Nine e-posters showcase efficacy and safety data for botulinum neurotoxin serotype E and onabotulinumtoxinA treatments.
Nine e-posters showcase efficacy and safety data for botulinum neurotoxin serotype E and onabotulinumtoxinA treatments.
The award recognizes over two decades of contributions to research, innovation, and education in the field of aesthetic medicine.